{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:09:28Z","timestamp":1715983768613},"reference-count":30,"publisher":"Georg Thieme Verlag KG","issue":"07","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Endocrinol Diabetes"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\nAims and Methods The declining ability to control blood glucose with advancement of age is an important health risk factor and may lead to insulin resistance, type-2-diabetes and Alzheimer\u2019s disease. Adenovirus 36(Ad36) improves glycemic control independent of insulin signaling(insulin sparing effect) as evidenced by cell, animal and observational human studies. This property of Ad36 may be useful in correcting aging-related glucose intolerance and related health conditions. Therefore, we determined the effect of Ad36 on glycemic control in older mice, to identify the age group that best responds to Ad36. Six, 12 or 20-month old C57Bl\/6 mice on chow diet were each divided into weight-matched groups(mock-infected or Ad36-infected). Body weight was recorded weekly post infection (p.i.) and fasting glucose measured(week 0, 4, 8 and 20 p.i.). Blood glucose and serum insulin were measured during glucose tolerance test(week 0 and 16 p.i.). At week 20 p.i., animals were sacrificed, blood and tissues collected.<\/jats:p><jats:p>\nResults Mice from all age groups showed improvement in glucose clearance post Ad36 infection, but a more profound effect was observed in 6-month old mice compared with mock-infected mice. Under fed conditions though there was no difference in blood glucose at 20 wk p.i., interestingly, Ad36 reduced serum insulin in age groups old mice, compared with control mice.<\/jats:p><jats:p>\nConclusions These findings suggest Ad36 infected animals improve glycemic control and clear post-prandial gluco00000se increase without increasing insulin secretion in an insulin sparing manner. These beneficial effects provide strong evidence for developing Ad36-based approaches as a novel tool to attenuate age associated glucose intolerance.<\/jats:p>","DOI":"10.1055\/a-0961-7804","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T23:01:39Z","timestamp":1564009299000},"page":"519-527","source":"Crossref","is-referenced-by-count":1,"title":["Improvement in Glycemic Control in Mice of Different Age Groups"],"prefix":"10.1055","volume":"129","author":[{"given":"Suhadinie","family":"Gamage","sequence":"additional","affiliation":[{"name":"Department of Nutritional Sciences, Obesity and Metabolic Health Laboratory, Texas Tech University, Lubbock, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swetha","family":"Peddibhotla","sequence":"additional","affiliation":[{"name":"Department of Nutritional Sciences, Obesity and Metabolic Health Laboratory, Texas Tech University, Lubbock, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Hemachandra","family":"Reddy","sequence":"additional","affiliation":[{"name":"Internal Medicine, Cell Biology and Biochemistry, Neuroscience\/Pharmacology and Neurology, Texas Tech University Health Sciences Center, Lubbock, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil V.","family":"Dhurandhar","sequence":"additional","affiliation":[{"name":"Department of Nutritional Sciences, Obesity and Metabolic Health Laboratory, Texas Tech University, Lubbock, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Hegde","sequence":"additional","affiliation":[{"name":"Department of Nutritional Sciences, Obesity and Metabolic Health Laboratory, Texas Tech University, Lubbock, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2019,7,24]]},"reference":[{"key":"ref2","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/CIRCRESAHA.118.312806","article-title":"Age-related changes in glucose metabolism, hyperglycemia, and cardiovascular risk","volume":"123","author":"C W Chia","year":"2018","journal-title":"Circ Res"},{"key":"ref3","first-page":"286","article-title":"Changes in diabetes-related complications in the United States","volume":"371","author":"E W Gregg","year":"2014","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/pop.2015.0181","article-title":"Diabetes 2030: Insights from yesterday, today, and future trends","volume":"20","author":"W R Rowley","year":"2017","journal-title":"Popul Health Manag"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1038\/sj.ejcn.1601032","article-title":"Carbohydrate metabolism in the elderly","volume":"54","author":"D Elahi","year":"2000","journal-title":"Eur J Clin Nutr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/dom.12719","article-title":"Effects of ageing and senescence on pancreatic beta-cell function","volume":"18 (Suppl) 1","author":"A Helman","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1172\/JCI10582","article-title":"Signaling pathways in insulin action: Molecular targets of insulin resistance","volume":"106","author":"J E Pessin","year":"2000","journal-title":"J Clin Invest"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/dc12-1089","article-title":"Long-term changes in adiposity and glycemic control are associated with past adenovirus infection","volume":"36","author":"W Y Lin","year":"2013","journal-title":"Diabetes Care"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/oby.2006.222","article-title":"Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats","volume":"14","author":"M Pasarica","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/1753-0407.12178","article-title":"Natural infection of human adenovirus 36 in rhesus monkeys is associated with a reduction in fasting glucose 36","volume":"6","author":"N V Dhurandhar","year":"2014","journal-title":"J Diabetes"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1093\/jn\/131.10.3155","article-title":"Human adenovirus Ad-36 promotes weight gain in male rhesus and marmoset monkeys","volume":"132","author":"N V Dhurandhar","year":"2002","journal-title":"J Nutr"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/sj.ijo.0801668","article-title":"Transmissibility of adenovirus-induced adiposity in a chicken model","volume":"25","author":"N V Dhurandhar","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.ijo.0801319","article-title":"Increased adiposity in animals due to a human virus","volume":"24","author":"N V Dhurandhar","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2337\/db07-1311","article-title":"Metabolically favorable remodeling of human adipose tissue by human adenovirus type 36","volume":"57","author":"P M Rogers","year":"2008","journal-title":"Diabetes"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2337\/db07-1313","article-title":"Human adenovirus type 36 enhances glucose uptake in diabetic and nondiabetic human skeletal muscle cells independent of insulin signaling","volume":"57","author":"Z Q Wang","year":"2008","journal-title":"Diabetes"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"E779","DOI":"10.1152\/ajpendo.00703.2010","article-title":"Template to improve glycemic control without reducing adiposity or dietary fat","volume":"300","author":"R Krishnapuram","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0025-7125(16)32479-8","article-title":"Aging and diabetes","volume":"55","author":"R Andres","year":"1971","journal-title":"Med Clin North Am"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.diabres.2006.09.010","article-title":"Thiazolidinediones and the risk of edema: A meta-analysis","volume":"76","author":"H D Berlie","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.2337\/diacare.26.11.2983","article-title":"Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: A retrospective cohort study","volume":"26","author":"T E Delea","year":"2003","journal-title":"Diabetes Care"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(07)61514-1","article-title":"Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: A meta-analysis of randomised clinical trials","volume":"370","author":"R M Lago","year":"2007","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1001\/jama.298.22.2634","article-title":"Thiazolidinediones and cardiovascular outcomes in older patients with diabetes","volume":"298","author":"L L Lipscombe","year":"2007","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2147\/VHRM.S4053","article-title":"Safety and efficacy of rosiglitazone in the elderly diabetic patient","volume":"5","author":"A Viljoen","year":"2009","journal-title":"Vasc Health Risk Manag"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1210\/jc.2009-2638","article-title":"Thiazolidinediones and fractures: Evidence from translating research into action for diabetes","volume":"95","author":"D Bilik","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1179\/acb.2008.083","article-title":"New therapeutic approaches in type 2 diabetes","volume":"63","author":"A J Scheen","year":"2008","journal-title":"Acta Clin Belg"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jdiacomp.2012.09.006","article-title":"Insulin sparing action of adenovirus 36 and its E4orf1 protein","volume":"27","author":"N V Dhurandhar","year":"2013","journal-title":"J Diabetes Complications"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1172\/JCI117909","article-title":"Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects","volume":"95","author":"L J Goodyear","year":"1995","journal-title":"J Clin Invest"},{"key":"ref27","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"R K Semple","year":"2009","journal-title":"J Clin Invest"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1210\/jcem-60-1-13","article-title":"Pathogenesis of age-related glucose intolerance in man: Insulin resistance and decreased beta-cell function","volume":"60","author":"M Chen","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/ageing\/afm076","article-title":"Oral glucose tolerance test in the assessment of glucose-tolerance in the elderly people","volume":"36","author":"R Stevic","year":"2007","journal-title":"Age Ageing"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5493\/wjem.v7.i1.1","article-title":"Effect of aging on stem cells","volume":"7","author":"A S Ahmed","year":"2017","journal-title":"World J Exp Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jdiacomp.2018.11.006","article-title":"Potential role of E4orf1 protein in aging-associated impairment in glycemic control","volume":"33","author":"S Gamage","year":"2019","journal-title":"J Diabetes Complications"}],"container-title":["Experimental and Clinical Endocrinology &amp; Diabetes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-0961-7804.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:34:04Z","timestamp":1626741244000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-0961-7804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,24]]},"references-count":30,"journal-issue":{"issue":"07","published-online":{"date-parts":[[2021,7,19]]},"published-print":{"date-parts":[[2021,7]]}},"URL":"https:\/\/doi.org\/10.1055\/a-0961-7804","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0947-7349","1439-3646"],"issn-type":[{"value":"0947-7349","type":"print"},{"value":"1439-3646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,24]]}}}